The glutathione S-transferase M1 (GSTM1) null genotype and benzidine- associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 12, 1996, Pages 979-983

  Rothman, Nathaniel ^a   Hayes, Richard B ^a   Zenser, Terry V ^b   DeMarini, David M ^c   Bi, Wenfang ^d   Hirvonen, Ari ^e   Talaska, Glenn ^f   Bhatnagar, Vijay K ^g   Caporaso, Neil E ^a   Brooks, Lance R ^c   Lakshmi, Vijaya M ^b   Feng, Peiwen ^h   Kashyap, Sri K ^g   You, Xiejun ⁱ   Eischen, Brent T ^c   Kashyap, Rekha ^g   Shelton, Melissa L ^c   Hsu, Fong F ^b   Jaeger, Marione ^f   Parikh, Dinesh J ^g   Davis, Bernard B ^b   Yin, Songnian ^d   Bell, Douglas A ^e   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (India)

^h Tianjin Organic Chemical Industrial Corporation Limited   (China)

ⁱ Shanghai Institute of Preventive Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIDINE; DNA; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ADDUCT; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTAGENICITY; PRIORITY JOURNAL; UROTHELIUM;

BENZIDINES; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; DNA ADDUCTS; DNA, NEOPLASM; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MUTAGENICITY TESTS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 16144362332     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ketterer, B. Protective role of glulathione and glutaihione transferase in mutagenesis and carcinogenesis. Mutat. Res., 202: 343-361, 1988.
2. Seidegard, J., and Pero, R. W. The hereditary transmission of high glutathione transferee activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet., 69: 66-68, 1985.
3. Mannervik, B., Alin, P., Guthenberg, C, Jensson, H., Tahir, M. K., Warholm, M., and Jornvall, H. Identification of three classes of cytosolic glutalhione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA, 82: 7202-7206, 1985.
4. Seidegard, J., Vorachek, W. R., Pero, R. W., and Pearson, W. R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA, 85: 7293-7297, 1988.
5. Lin, H. J., Han, C. Y., Bernstein, D. A., Hsiao, W., Lin, B. K., and Hardy, S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis (Lond.), 15: 1077-1081, 1994.
6. Lafuente, A., Pujol, F., Carretero, P., Villa, J. P., Cuchi, A. Human glutathione S-transferase μ (GSTμ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68: 49-54, 1993.
7. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85: 1159-1164, 1993.
8. Daly, A. K., Thomas, D. J., Cooper, J., Pearson, W. R., Neal, D. E., and Idle, J. R. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. Br. Med. J., 307: 481-482, 1993.
9. Chem, H. D., Romkes-Sparks, M., Hu, J. J., Persad, R., Sibley, G. A., Smith, P. J. B., and Branch, R. A. Homozygous deleted genotype of glutathione S-transferase Ml increases susceptibility to aggressive bladder cancer. Proc. Am. Assoc. Cancer Res., 35: 285, 1994.
10. Katoh, T., Inatomi, H., Nagaoka, A., and Sugita, A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis (Lond.), 16: 655-657, 1995.
11. Brockmoller, J., Cascorbi, C., Kerb, R., and Roots, I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione 5-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56: 3915-3925, 1996.
12. Zhong, S., Wyllie, A., H., Barnes, D., Wolf, C. R., and Spurr, N. K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (Lond.), 14: 1821-1824, 1993.
13. Bi, W., Hayes, R. B., Feng, P., Qi, Y., You, X., Zhen, J., Zheng, M., Qu, B., Fu, Z., Chen, M., Co Chien, H. T., and Blot, W. J. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am. J. Ind. Med., 21: 481-489, 1992.
14. Hayes, R. B., Bi, W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L., and Meyer, U. A. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis (Lond.), 14: 675-678, 1993.
15. Thomas, D. G., and Gart, J. J. Improved and extended exact and asymptotic methods for the combination of 2 X 2 tables. Version 2.03. Comput. Biomed. Res., 25: 75-84, 1992.
16. Rothman, N., Bhatnagar, V. K., Hayes, R. B., Zenser, T. V., Kashyap, S. K., Butler, M. A., Bell, D. A., Lakshmi, V., Jaeger, M., Kashyap, R., Hirvonen, A., Schulte, P. A., Dosemeci, M., Hsu, F., Parikh, D. J., Davis, B. B., and Talaska, G. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. USA. 93: 5084-5089, 1996.
17. Chen, H., Sandier, D. P., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C. D., and Bell, D. A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase θ 1 (GSTT1) gene defect. Lancet, 347: 295-297, 1996.
18. Maron, D. M., and Ames, B. N. Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113: 173-215, 1983.
19. Watanabe, M., Ishidate, M., Jr., and Nohmi, T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acelyltransferase levels. Mutat. Res., 234: 337-348, 1990.
20. Fields, W. R., Li, Y., and Townsend, A. J. Protection by transfected glutathione S-transferase isozymes against carcinogen-induced alkylation of cellular macromolecules in human MCF-7 cells. Carcinogenesis (Lond.), 15: 1155-1160, 1994.
21. Stanley, J. S., York, J. L., and Benson, A.M. Nitroreductases and glutathione transferases that act on 4-nitroquinolone I-oxide and their differential induction by butylated hydroxanisole in mice. Cancer Res., 52: 58-63, 1992.
22. Hirvonen, A., Nylund, L., Kociba, P., Husgafvel-Pursiainen, K., and Vainio, H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis (Lond.), 15: 813-815, 1994.
23. Yu, M. C., Ross, R. K., Chan, K. K., Henderson, B. E., Skipper, P. L., Tannenbaum, S. R., and Coetzee, G. A. Glutathione 5-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol., Biomarkers & Prev., 4: 861-864, 1995.
24. Bartsch, H., Malaveille, C., Friesen, M., Kadlubar, F. F., and Vineis, P. Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J. Cancer, 29A: 1199-1207, 1993.